Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
511414
Reference Type
Journal Article
Title
A case of primary botryoid conjunctival rhabdomyosarcoma
Author(s)
Polito, E; Pichierri, P; Loffredo, A; Lasorella, G
Year
2006
Is Peer Reviewed?
Yes
Journal
Graefe's Archive for Clinical and Experimental Ophthalmology
ISSN:
0721-832X
EISSN:
1435-702X
Volume
244
Issue
4
Page Numbers
517-519
Language
English
DOI
10.1007/s00417-005-0085-5
Abstract
Background: Rhabdomyosarcoma is the most common childhood primary orbital malignancy, but the occurrence of this tumour in the conjunctiva is rare. Methods: A 14-year-old girl presented with a visible case of conjunctival mass in the left eye. The year before, the patient was referred to another hospital for a biopsy of a conjunctival mesenchymal tumour in the same site, which was periodically checked after the excision. We intervened by partially removing the conjunctival mass. Results: The histopathology revealed a botryoid rhabdomyosarcoma. The patient underwent chemotherapy and fractionated radiotherapy. The follow-up after three years revealed that the patient remained clinically tumor-free, with no ocular complication from the radiotherapy. Conclusions: It is evident that by not excising the tumour in its entirety it is therefore possible to preserve the underlying rectus muscles and not interfere with ocular motility. Subsequent radiotherapy and chemotherapy helped to destroy any residual tumour. Alternatively, surgical excision of the mass alone could lead to recurrence of the tumour after some months or years.
Keywords
embryonal rhabdomyosarcoma
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity